Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones

Bristol-Myers Squibb announced first-quarter results that included double-digit earnings growth and important R&D milestones in its metabolics and hepatitis C franchises.
MarketWatch